Tandem Diabetes Care Inc, Product Pipeline Analysis Q4, 2019 Update - Overview, Key Facts & Key Competitors - ResearchAndMarkets.com

DUBLIN--()--The "Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering.

Summary

Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect application and tandem device updater. Tandem offers a wide range of accessories and supplies to help its clients to further customize their systems. It markets its products through its distribution network. Tandem is headquartered in San Diego, California, the US

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Tandem Diabetes Care Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Key Topics Covered:

  • Tandem Diabetes Care Inc Company Overview
  • Tandem Diabetes Care Inc Company Snapshot
  • Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Tandem Diabetes Care Inc - Pipeline Analysis Overview
  • Tandem Diabetes Care Inc - Key Facts
  • Tandem Diabetes Care Inc - Major Products and Services
  • Tandem Diabetes Care Inc Pipeline Products by Development Stage
  • Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
  • Tandem Diabetes Care Inc Pipeline Products Overview
  • AutoSoft XC
  • AutoSoft XC Product Overview
  • Connected Health Mobile App
  • Connected Health Mobile App Product Overview
  • Next Generation Gswim
  • Next Generation Gswim Product Overview
  • t:connect Mobile
  • t:connect Mobile Product Overview
  • t:slim X2 Control-IQ System - Pediatrics
  • t:slim X2 Control-IQ System - Pediatrics Product Overview
  • t:slim X2 Control-IQ System - Pediatrics Clinical Trial
  • t:slim X2 Pump With Dexcom G6 and HCL
  • t:slim X2 Pump With Dexcom G6 and HCL Product Overview
  • t:slim X2 Pump With Dexcom G6 and HCL Clinical Trial
  • t:sport
  • t:sport Product Overview
  • Tandem Diabetes Care Inc - Key Competitors
  • Tandem Diabetes Care Inc - Key Employees
  • Tandem Diabetes Care Inc - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • Tandem Diabetes Care Inc, Recent Developments
  • Nov 20, 2019: Tandem Diabetes Care announces Health Canada approval of t:slim X2 Insulin Pump with Basal-IQ predictive low-glucose suspend technology
  • Nov 04, 2019: Tandem Diabetes Care announces third quarter 2019 financial results and updated 2019 financial guidance
  • Nov 01, 2019: 2019 Beyond Type Run team to race the TCS New York City Marathon using Basal-IQ Technology from Tandem Diabetes Care
  • Oct 30, 2019: Tandem Diabetes Care presents positive real-world data from pediatric users of t:slim X2 Insulin Pump with Basal-IQ Technology at International Conference
  • Oct 17, 2019: Artificial pancreas system shows promise in clinical trial
  • Oct 16, 2019: Tandem Diabetes Care Announces NEJM Publication of landmark study demonstrating increased time-in-range with the t:slim X2 Insulin Pump with Control-IQ Technology
  • Sep 18, 2019: andem Diabetes Care announces publication of Real-world Basal-IQ predictive low glucose suspend technology data in Diabetes Technology and Therapeutics Journal
  • Aug 01, 2019: Tandem Diabetes Care announces second quarter 2019 financial results and updated 2019 financial guidance
  • Aug 01, 2019: Tandem Diabetes Care announces no-cost software updates for t:slim X2 Insulin Pump customers in the United States
  • Jun 09, 2019: Tandem Diabetes Care reports positive results from two studies of the t:slim X2 Insulin Pump With Control-IQ Technology
  • Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer

Companies Mentioned

  • Insulet Corp
  • IRadimed Corp
  • Stryker Corp
  • Adherium Ltd

For more information about this company profile visit https://www.researchandmarkets.com/r/u8w4zj

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900